Endpoints News 2. Juni 2026 Allen Institute launches $200M effort to turn brain atlas lessons into medicines
Endpoints News 1. Juni 2026 The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that way
Endpoints News 1. Juni 2026 Shionogi wins US approval for first pill to prevent Covid following exposure
Endpoints News 1. Juni 2026 #ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T update
Endpoints News 1. Juni 2026 After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listing
Endpoints News 1. Juni 2026 Servier signs $1.55B upfront deal for Edgewise's muscular dystrophy assets
Endpoints News 1. Juni 2026 #ASCO26: Erleada succeeds in early-stage prostate cancer study, but questions remain
Endpoints News 31. Mai 2026 #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study
Endpoints News 31. Mai 2026 #ASCO26: Personalized cancer vaccines may help brain cancer patients live longer
Endpoints News 30. Mai 2026 #ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts say